Publication | Open Access
Phase II study of oral S‐1 for treatment of metastatic colorectal carcinoma
116
Citations
26
References
2004
Year
Orally administered S-1 is active against metastatic colorectal carcinoma and has an acceptable toxicity profile. This promising agent has the potential to become a valuable chemotherapeutic option.
| Year | Citations | |
|---|---|---|
Page 1
Page 1